Assessment of Quality of Life of Children With Chronic Idiopathic Thrombocytopenic Purpura (Kid's ITP Tools)

Diagnostic of Chronic Thrombocytopenia

NCT04071496 ·Status: COMPLETED

Immunological Markers in Adult Patients With Immune Thrombocytopenic Purpura

NCT04056507 ·Status: COMPLETED

"Cytotoxic T Lymphocyte-Associated Antigen-4 (CTLA-4) Gene Single-nucleotide Polymorphism in Primary Immune Thrombocytopenic Purpura in Children"

NCT07014904 ·Status: NOT_YET_RECRUITING

Study of the Role of Regulator T Cells in the Pathophysiology of Childhood Henoch Schönlein Purpura

NCT02317133 ·Status: COMPLETED

Evaluation of HRQoL in Adult With Immune Thrombocytopenia in China

NCT03324087 ·Status: UNKNOWN

An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers

NCT00005570 ·Status: COMPLETED

Steroid Resistance in Pediatric Immune Thrombocytopenic Purpura

NCT06601543 ·Status: NOT_YET_RECRUITING

Thrombopoietin Agonists in Patients With Idiopathic Thrombocytopenic Purpura

NCT06137105 ·Status: NOT_YET_RECRUITING

Lymphocyte Counts in Immune Thrombocytopenic Purpura

NCT03244410 ·Status: UNKNOWN

Retrospective Study on Caplacizumab-treated Pediatric Patients With Immune-mediated Thrombocytopenic Purpura (iTTP)

NCT05263193 ·Status: COMPLETED

NATURAL KILLER CELLS IN IMMUNOLOGIC THROMBOCYTOPENIC PURpura of Adults

NCT01172015 ·Status: COMPLETED ·Phase: NA

Anti-CD38 Antibody Treating Pediatric Primary Immune Thrombocytopenia (ITP)

NCT06168851 ·Status: RECRUITING ·Phase: PHASE2

Prevalence of Thyroid Disorders in Patients With Immune Thrombocytopenic Purpura and Its Impact on Treatment

NCT07059910 ·Status: NOT_YET_RECRUITING

A Study Evaluating the Safety and Efficacy of Long-term Dosing of Romiplostim in Thrombocytopenic Pediatric Patients With Immune (Idiopathic) Thrombocytopenia Purpura

NCT01071954 ·Status: COMPLETED ·Phase: PHASE3

Eltrombopag in Chronic ITP

NCT04102033 ·Status: UNKNOWN ·Phase: PHASE4

Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body.

NCT01520909 ·Status: COMPLETED ·Phase: PHASE3

Research of Predictive Factors to Immune Thrombopenic Purpura

NCT01648556 ·Status: COMPLETED ·Phase: NA

Helicobacter Pylori Treatment in Immune Thrombocytopenic Purpura (ITP) Patients

NCT01730352 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Anti-CD38 Antibody Treating Children With Primary Immune Thrombocytopenia (ITP)

NCT06838962 ·Status: RECRUITING ·Phase: PHASE2

Immune Markers in Pediatric ITP on Second Line Therapy

NCT06093529 ·Status: NOT_YET_RECRUITING

A Prospective Study on the Long-Term Vascular Burden in Thrombotic Thrombocytopenic Purpura Patients

NCT03187652 ·Status: RECRUITING

Safety of Oral Thrombopoietin Receptor Agonist in Pediatric Chronic ITP

NCT05846529 ·Status: UNKNOWN

Safety and Efficacy Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients

NCT02614846 ·Status: UNKNOWN ·Phase: PHASE1

The Outcome of the Thrombopoietin Receptor Agonists in Pediatric Patient With Persistent or Chronic ITP Unresonsive to Steroids

NCT06568913 ·Status: RECRUITING ·Phase: NA

Prospective Psychometric Evaluation Study of a Patient-reported Outcomes (PRO) Instrument for Congenital Thrombotic Thrombocytopenic Purpura (cTTP, Upshaw-Schulman Syndrome [USS], Hereditary Thrombotic Thrombocytopenic Purpura [hTTP]

NCT03519672 ·Status: COMPLETED